摘要
目的观察糖骨康对糖尿病骨质疏松患者骨密度(BMD)、空腹血糖(FBG)、糖化血红蛋白(HbA1c)及血清骨钙素(BGP)、钙(Ca)、磷(P)以及尿Ca、P含量的影响。方法将139例糖尿病骨质疏松患者随机分为治疗组74例与对照组65例,治疗组服用中药糖骨康汤剂,对照组服用盖天力片,30d为1疗程;治疗前后检测BMD、FBG、HbA1c和血清BGP、Ca、P以及尿Ca、P指标情况。结果治疗后两组BMD和血清BGP显著上升,FBG、HbA1c和尿Ca、P含量显著下降,治疗组改善优于对照组。结论糖骨康具有调节糖尿病骨质疏松患者Ca、P代谢,降低血糖,抑制骨质疏松的作用。
Objective: To observe the effect of Tanggukang Decoction on bone density(BMD), fasting blood glucose(FBG), glycosylated hemoglobin(HbAlc), the content of bone gla protein(BGP), calcium(Ca), phosphours (P)in the serum and Ca, P in urine of patients of diabetes with osteoporosis. Methods: 139 cases patients of diabetes with osteoporosis were divided into two groups. The treatment group( n = 74)were treated by Tanggukang Decoction, and control group ( n = 65) were treated by Gaitianli Tablet, with one treatment period of 30d. The BMD, FBG, HbA1c, and the content of BGP, Ca, P in the serum and Ca, P in urine were measured before and after treatment. Results: The BMD and BGP of serum increased significantly, and the FBG, HbAlc and the content Ca, P in urine decreased significantly in both group after treatment. The treatment group was more improved than those of control group. Conclusion: Through regulating the metabolism of Ca and P, Tanggukang Decoction could decrease fasting blood sugar, and prevent the osteoporosis of patients with diabetes.
出处
《中国中医急症》
2009年第1期45-46,62,共3页
Journal of Emergency in Traditional Chinese Medicine
基金
河北省中医药管理局科研项目(No.2007203)
关键词
糖尿病
骨质疏松
骨钙素
钙磷代谢
糖骨康
Diabetes
Osteoporosis
Bone gla protein
The metabolism of calcium and phosphours
Tanggukang Decoction